Technogenetics SRL manufactures and markets healthcare and diagnostics products. It specializes in the production and commercialization of IVD kits for autoimmune and infectious diseases, offers a complete line of analytes for the diagnosis of the ToRCH complex (Toxo IgG, Toxo IgM, Toxo IgG Avidity, Rubella IgG, Rubella IgM, Rubella IgG Avidity, CMV IgG, CMV IgM, CMV IgG Avidity, HSV 1 IgG, HSV 2 IgG, HSV 1/2 IgM) on the new random access platform, in chemiluminescence, TGS Analyser TA 120 (Technogenetics Total Automation). The company was founded in 1982 and is headquartered in Lodi, Italy.

Gruppo Lepetit SRL, part of Sanofi, is a company headquartered in Italy. The firm manufactures pharmaceuticals and proprietary medicines, medical and surgical supplies.

Develops medical devices

Scryb, Inc. operates as a medical technology company, which engages in the development of novel medical devices for in vitro diagnostics and point-of-care testing. Its platform technologies include HemoPalm and Pharmatrac. The HemoPalm develops a POCT unit-use cartridge based blood analyzer with full enterprise capabilities. The Pharmatrac is an AI and data analytics driven personal medication management system that addresses the growing problem of non-adherence to treatment. The company was founded by James Samsoondar in 2005 and is headquartered in Toronto, Canada.

Foshan Nanhai District Prosanta Biotechnology Co., Ltd., established on 2016-03-30, Business scope includes medical research and experimental development;Cosmetic Manufacturing,Nutritional Food Manufacturing,Health food manufacturing;Retailing of cosmetics and hygiene products;Wholesale of nutrition and health products,Nutrition and Supplement Retailing.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments.)(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Instytut Chemii Bioorganicznej Pan (doing business as Institute of Bioorganic Chemistry) is a Polish company ultimately controlled by the Government of Poland. The firm operates as a physical-chemical biology and biotechnology center.

Part of Sanofi, Henning Berlin is a German company that manufactures and distributes durgs and medicines. On September 01, 1996 Synth��labo SA acquired Henning Berlin from Hoechst AG.

Roussel UCLAF.

Yeda Research and Development Company Ltd. is the commercial arm of the Weizmann Institute of Science. Yeda holds an exclusive agreement with the Weizmann Institute to commercialize the unique intellectual property developed by the scientists. The income generated serves to support further basic research and science education. - Identify and assess research projects with commercial potential. - Protect the intellectual property of the Institute and its scientists. - Create business relationships and license the Institute’s inventions and technologies to the industry. - Channel funding from industry to research projects. For further information please contact Tamir Huberman, CIO and Head of Marketing

Manufactures biological products

Sclavo Spa is an Italian private company located in Siena that operates as a laboratory.

KOFA provides biomedicine. They provide quantitative solutions and services for clinical medical diagnosis, conduct research, and develop clinical diagnostic technology. They manufacture and sell biomedicine.

Hoechst AG produced specialty chemicals and pharmaceutical products. It products ranged in areas of heart cycle, thrombose, central nervous system, onkologie, diabetes, metabolic illnesses, internal medicine and vaccines. Founded in 1863, the company was headquartered in Frankfurt am Main, Germany.

Takeda Pharmaceutical Company Ltd (武田薬品工業株式会社 Takeda Yakuhin Kōgyō Kabushiki-gaisha) is the largest pharmaceutical company in Asia and one of the top 20 largest pharmaceutical companies in the world by revenue (top 10 following merger with Shire). The company has over 30,000 employees worldwide and achieved 16.2 billion USD in revenue during the 2012 fiscal year. The company is focused on metabolic disorders, gastroenterology, neurology, inflammation, as well as oncology through its independent subsidiary, Takeda Oncology. Its headquarters is located in Chuo-ku, Osaka, and it has an office in Nihonbashi, Chuo, Tokyo. In January 2012, Fortune Magazine ranked the Takeda Oncology Company as one of the 100 best companies to work for in the United States.

Repligen Corporation is a life sciences company focused on the development and commercialization of high-value consumable products used in the process of manufacturing biological drugs. Our bioprocessing products are sold to major life sciences and biopharmaceutical companies worldwide. We are the leading manufacturer of Protein A affinity ligands, a critical component of Protein A resins that are used to separate and purify monoclonal antibody therapeutics. Our ATF (Alternating Tangential Flow) systems and our growth factor products are used to increase product yield during the fermentation stage of biologic drug manufacturing. In addition, we developed and market an innovative line of “ready-to-use” chromatography columns under our OPUS® and MediaScout® brands that we deliver pre-packed with our customers’ choice of resin. Repligen’s corporate headquarters are in Waltham, MA (USA) and our manufacturing facilities are located in Waltham, MA, Lund, Sweden and Weingarten, Germany.